- Home
- CMMB vs OM Comparison
CMMB vs OM Comparison
Compare CMMB & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- OM
- Stock Information
- Founded
- CMMB 2004
- OM 2003
- Country
- CMMB Israel
- OM United States
- Employees
- CMMB N/A
- OM N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CMMB Health Care
- OM Health Care
- Exchange
- CMMB Nasdaq
- OM Nasdaq
- Market Cap
- CMMB 22.0M
- OM 305.5M
- IPO Year
- CMMB N/A
- OM 2020
- Fundamental
- Price
- CMMB $1.17
- OM $18.81
- Analyst Decision
- CMMB Strong Buy
- OM Buy
- Analyst Count
- CMMB 2
- OM 2
- Target Price
- CMMB $8.50
- OM $33.00
- AVG Volume (30 Days)
- CMMB 182.0K
- OM 499.3K
- Earning Date
- CMMB 08-20-2025
- OM 08-06-2025
- Dividend Yield
- CMMB N/A
- OM N/A
- EPS Growth
- CMMB N/A
- OM N/A
- EPS
- CMMB N/A
- OM N/A
- Revenue
- CMMB N/A
- OM $115,273,000.00
- Revenue This Year
- CMMB N/A
- OM $10.80
- Revenue Next Year
- CMMB N/A
- OM $11.99
- P/E Ratio
- CMMB N/A
- OM N/A
- Revenue Growth
- CMMB N/A
- OM N/A
- 52 Week Low
- CMMB $0.87
- OM $5.85
- 52 Week High
- CMMB $2.55
- OM $72.60
- Technical
- Relative Strength Index (RSI)
- CMMB 42.36
- OM 46.15
- Support Level
- CMMB $1.17
- OM $19.94
- Resistance Level
- CMMB $1.23
- OM $21.36
- Average True Range (ATR)
- CMMB 0.05
- OM 1.31
- MACD
- CMMB 0.00
- OM -0.22
- Stochastic Oscillator
- CMMB 30.30
- OM 40.06
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.